Phase IV Trial,The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Acute Upper Respiratory Infection

Clinical trial NCT02654158 · COMPLETED

Trial details

NCT number: NCT02654158
Sponsor: Guangzhou Yipinhong Pharmaceutical CO.,LTD
Status: COMPLETED
Study type: OBSERVATIONAL

Acute Upper Respiratory Infection

Start date: 2013-08-01
Primary completion: 2017-05-01
Enrollment: 2400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.